Outcome of HCV/HIV-coinfected liver transplant recipients: A prospective and multicenter cohort study

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1866-1876

  Miro, J M ^a,w   Montejo, M ^b   Castells, L ^c,d,w   Rafecas, A ^a,r,w   Moreno, S ^e   Aguero F ^a   Abradelo, M ^f   Miralles, P ^g,w   Torre Cisneros, J ^h,w   Pedreira, J D ^i,m   Cordero, E ^j   de la Rosa, G ^k,w   Moyano, B ^l   Moreno, A ^a,w   Perez, I ^a   Rimola, A ^a,d,w   Castro, M A ^m   Lopez S ^m   Suarez F ^m   Vazquez P ^m   Blanch, J ^a   Brunet, M ^a   Cervera, C ^a   de Lazzari, E ^a   Fondevila, C ^a   Forner, A ^a   Fuster, J ^a   Freixa, N ^a   Garcia Valdecasas J C ^a   Gil, A ^a   Gatell, J M ^a   Laguno, M ^a   Larrousse, M ^a   Mallolas, J ^a   Manzardo, C ^a   Monras M ^a   Murillas, J ^a   Paredes, D ^a   Perez I ^a   Torres, F ^a   Tural, C ^a   Tuset, M ^a   Antela, A ⁿ   Losada, E ⁿ   Molina, E ⁿ   Otero, E ⁿ   Varo, E ⁿ   Lozano, R ^o   Araiz, J J ^o   Barrao, E ^o   Larraga, J ^o   Letona, S ^o   Luque, P ^o   Navarro, A ^o   Sanjoaquin I ^o   Serrano, T ^o   Tejero, E ^o   Salcedo, M ^g   Banares R ^g   Berenguer, J ^g   Clemente, G ^g   Cosin J ^g   Ferreiroa, J P ^g   Garcia Sabrido J L ^g   Gutierrez I ^g   Lopez J C ^g   Ramirez M ^g   Rincon D ^g   Sanchez M ^g   Jimenez M ^p   de la Cruz, J ^p   Fernandez J L ^p   Lozano, J M ^p   Santoyo, J ^p   Rodrigo, J M ^p   Suarez M A ^p   Rodriguez M ^q   Alonso, M P ^q   Asensi, V ^q   Gonzalez Dieguez M L ^q   Gonzalez Pinto I ^q   Baliellas, C ^r   Carratala J ^r   Fabregat, J ^r   Fernandez N ^r   Jorba, R ^r   Llado L ^r   Xiol, X ^r   Bustamante, J ^b   Fernandez J R ^b   Gastaca, M ^b   Gonzalez J ^b   Montejo, E ^b   Ortiz de Urbina, J ^b   Ruiz, P ^b   Suarez M J ^b   Testillano, M ^b   Valdivieso, A ^b,w   Ventoso, A ^b   Calvo, J ^f   Costa, J R ^f   Garcia Sesma A ^f   Jimenez C ^f   Manrique, A ^f   Meneu, J C ^f   Moreno, E ^f   Moreno, V ^f   Olivares, S P ^f   Pulido, F ^f   Rubio, R ^f   Blanes, M ^s   Aguilera, V ^s   Berenguer, M ^s   Lopez J ^s   Lopez R ^s   Prieto, M ^s   Farinas M C ^t   Casafont, F ^t   Echevarria, S ^t   Fabrega E ^t   Garcia Palomo J D ^t   Gomez Fleitas, M ^t   Gutierrez Cuadra M ^t   Saravia, G ^t   Barcena, R ^e   Del Campo, S ^e   Martin Davila P ^e   Fortun J ^e,w   Moreno, A M ^e   Barrera, P ^h   Briceno J ^h   Caston, J J ^h   Costan, G ^h   de la Mata, M ^h   Lara, R ^h   Lopez Cillero P ^h   Montero, J L ^h   Rivero, A ^h   Rufian, S ^h   Castells, L L ^c   Bilbao, I ^c   Campos Varela, I ^c   Charco, R ^c   Esteban, J I ^c   Gavalda J ^c   Len, O ^c   Pahissa, A ^c   Ribera, E ^c   Vargas, V ^c   Pons, J A ^u   Bernal, C ^j   Cisneros, J M ^j   Gomez M A ^j   Pascasio, J M ^j   Rodriguez M J ^j   Sayago, M ^j   Sousa, J M ^j   Suarez G ^j   Gonzalez Garcia J ^l,v,w   Aznar, E ^l   Barquilla, E ^l   Esteban, H ^l   Guerra, L ^w   Lozano, F ^w   Manzanera, M ^w   Stock, P ^w   Roland, M ^w   Samuel, D ^x   Mazardo, C ^a   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ Hospital Univiversitario de A Coruña   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k Organizacin Nacional de Trasplante (ONT)   (Spain)

^l Fundacion SEIMC GESIDA   (Spain)

^m Hospital Universitario de A Coruna   (Spain)

ⁿ Instituto de Salud Carlos III   (Spain)

^o HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^p HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^q HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^r HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^s HOSPITAL UNIVERSITARIO LA FE   (Spain)

^t HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^u HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^v HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^w UNIVERSITY OF SAN FRANCISCO   (United States)

^x HÔPITAL PAUL BROUSSE   (France)

more..

Author keywords

HCV infection; HIV infection; Liver transplantation; Spain; Survival

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 84863300076     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04028.x     Document Type: Article

References (34)

1. Hogg R, Lima V, Sterne JA, et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-299.
2. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492-497. (Pubitemid 32173638)
3. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: Results from the EuroSIDA study. AIDS 2002; 16: 1663-1671. (Pubitemid 34921112)
4. Martínez E, Milinkovic A, Buira E, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007; 8: 251-258. (Pubitemid 46695372)
5. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188: 1412-1420. (Pubitemid 37523925)
6. Miro JM, Laguno M, Moreno A, Rimola A. Hospital Clinic Olt In Hiv Working Group. Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT)? J Hepatol 2006; 44(1 Suppl): S140-S145. (Pubitemid 43053890)
7. Tateo M, Roque-Afonso AM, Antonini TM, et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: Perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS 2009; 23: 1069-1076.
8. Coffin CS, Stock PG, Dove LM, et al. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant 2010; 10: 1268-1275.
9. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: Analysis of United Network for Organ Sharing database. Transplantation 2008; 85: 359-368. (Pubitemid 351322759)
10. de Vera ME, Dvorchik I, Tom K, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
11. Duclos-Vallée JC, Féray C, Sebagh M, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407-417. (Pubitemid 351280708)
12. Rafecas A, Rufí G, Fabregat J, Xiol X. Liver transplantation in a patient infected with HIV. Med Clin (Barc) 2002; 119: 596.
13. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-90. (Pubitemid 43345017)
14. Centers for Disease Control and prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 8;41(RR-17): 1-19.
15. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 7th edn. Philadelphia, PA. Churchill Livingston: Elsevier, 2010.
16. Busuttil RW, Klintmalm GK. Transplantation of the Liver. 2nd edn. Philadelphia: Elsevier Saunders, 2005.
17. Miro JM, Torre-Cisneros J, Moreno A, et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005). Enferm Infecc Microbiol Clin 2005; 23: 353-362. (Pubitemid 41020547)
18. Iribarren JA, Labarga P, Rubio R, et al. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infec Microbiol Clin 2004; 22: 564-642.
19. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658-663.
20. Panel de expertos de Grupo de Estudio del Sida; Plan Nacional sobre el Sida. [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan]. Enferm Infecc Microbiol Clin 2008; 26: 437-464.
21. Ayats-Ardite J, Cisneros-Herreros JM, Pérez-Sáenz JL, de la Torre-Cisneros J. [Infectious disease assessment in solid organ transplant candidates]. Enferm Infecc Microbiol Clin 2002; 20: 448-461.
22. Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl 2009; 15(Suppl. 2): S35-S41.
23. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293. (Pubitemid 26260021)
24. Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology 1999; 29: 365-370 (Pubitemid 29088438)
25. Gayowski T, Singh N, Marino IR, et al. Hepatitis C virus genotypes in liver transplant recipients: Impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64: 422-426. (Pubitemid 27349881)
26. Roche B, Samuel D. Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hepat 2007; 14(Suppl 1): 89-96. (Pubitemid 47624117)
27. Schreibman I, Gaynor JJ, Jayaweera D, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84: 697-705. (Pubitemid 47480654)
28. Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl 2009; 15: 592-599.
29. Berenguer M. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 2008; 49: 274-287.
30. Miro JM, Aguero F, Laguno M, et al. Liver transplantation in HIV/hepatitis co-infection. J HIV Ther 2007; 12: 24-35.
31. Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med 1999; 41: 2049-2053. (Pubitemid 30035953)
32. Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004; 4: 920-927. (Pubitemid 38745591)
33. Scarborough JE, Pietrobon R, Tuttle-Newhall JE, et al. Relationship between provider volume and outcomes for orthotopic liver transplantation. J Gastrointest Surg 2008; 12: 1527-1533.
34. Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.